학술논문
Intravitreal Nesvacumab (Anti-Angiopoietin-2) Plus Aflibercept in Neovascular AMD: Phase 2 ONYX Randomized Trial
Document Type
Article
Author
Source
In: Journal of VitreoRetinal Diseases . (Journal of VitreoRetinal Diseases, January/February 2023, 7(1):8-15)
Subject
Language
English
ISSN
24741272
24741264
24741264